Your search returned no results.
Anal dysplasia can lead to cancer, but is easily missed because it causes few symptoms and is a stigmatized condition. Regular checkups and the HPV vaccine can protect you.
Cedars-Sinai is working to understanding how the immune system of cancer patients responds to COVID-19 vaccinations to address the pandemic and can help prepare for the next.
Clinical trials are important for medical progress, but there's long been a lack of diversity in clinical trial participants. Researchers at Cedars-Sinai are working as a team to a...
Patients who receive gender-affirming care still need to consider their cancer risks. A new “screen what you have” approach considers each patient by their organs—not their gender.
Cedars-Sinai scientists are using stem cell technology in an effort to predict the risk and severity of ovarian cancer in women with BRCA mutations.
Cedars-Sinai Cancer has joined with precision medicine firm Tempus to design cancer treatment options that are increasingly personalized. The partnership harnesses artificial intel...
Public health efforts and scientific advances have led to a significant drop in lung cancer deaths, but researchers are still searching for cures for the No. 1 cancer scourge.
Cedars-Sinai scientists and surgeons are at the forefront of reducing the risk of bladder cancer recurrence. Learn more.
Cedars-Sinai investigators are leveraging machine learning to help glean insights into disease prediction and assist with expeditious detection.
Ruthie Krivis has been volunteering at Cedars-Sinai for 42 years. For National Volunteer Week, we talked to Ruthie about the impact she's made as a volunteer and how rewarding givi...
Cedars-Sinai Blog / Apr 18, 2022
Melding together Mayan imagery and modern medicine, a Cedars-Sinai oncologist hopes to raise awareness of the prevalence—and curability—of leukemia in Latinos.
Cedars-Sinai Blog / Apr 15, 2022